Three patients with a fracture during methotrexate use, possibly due to methotrexate osteopathy;Drie patiënten met een botfractuur tijdens het gebruik van methotrexaat, mogelijk door methotrexaatosteopathie

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 43, 2008, Pages 2357-2360

  Van Der Bijl, A E ^a   Zijlstra, T R ^a   Engelage, A H ^a   Posthuma, B J M ^a   Van Veen, G J M ^a  

^a Locatie Weezenlanden   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTHRITIS; ARTICLE; BODY WEIGHT; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FRACTURE; HUMAN; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; X RAY;

AGED; BONE DISEASES, METABOLIC; FEMALE; FRACTURES, STRESS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; METHOTREXATE; MIDDLE AGED; OSTEOPOROSIS; REMISSION, SPONTANEOUS;

EID: 55349100944     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350:2591-602.
2. Mease P. Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Curr Rheumatol Rep. 2006;8:348-54.
3. Farmacotherapeutisch kompas 2008. Diemen: College voor zorgverzekeringen; 2008.
4. Ragab AH, Freeh RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25:580-5.
5. Eekhoff EMW, Pinedo HM, Lips P. Osteoporose bij patiënten die worden behandeld wegens kanker en de mogelijkheden voor preventie en behandeling. Ned Tijdschr Geneeskd. 2007;151:1388-93.
6. Schwartz AM, Leonidas JC. Methotrexate osteopathy. Skelet Radiol. 1984;11:13-6.
7. Alonso-Bartolome P, Martinez-Taboada VM, Canga A, Blanco R. Medial tibial stress syndrome due to methotrexate osteopathy. Ann Rheum Dis. 2006;65:832-3.
8. Stevens H, Jacobs JWG, Rijk PP van, Klerk JMH de. Methotrexate osteopathy demonstrated by Technetium-99m HDP bone scintigraphy. Clin Nucl Med. 2001;26:389-91.
9. Wijnands M, Burgers A. Stress fracture in long term methotrexate treatment for psoriatic arthritis. Ann Rheum Dis. 2001;60:736-9.
10. Rudler M, Pouchot J, Paycha F, Gentelle S, Grasland A, Vinceneux P. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis. Ann Rheum Dis. 2003;62:588-9.
11. Zonneveld IM, Bakker WK, Dijkstra PF, Bos JD, Soesbergen RM van, Dinant HJ. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol. 1996;132:184-7.
12. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis. 1993;52:582-5.
13. Peris P. Stress fractures in rheumatological practice: clinical significance and localizations. Rheumatol Int. 2002;22:77-9.
14. Dequeker J, Maenaut K, Verwilghen J, Westhovens R. Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol. 1995;12(Suppl. 12):S21-6.
15. Uehara R, Suzuki Y, Ichikawa Y. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy. J Rheumatol. 2001;28:251-6.
16. Minaur NJ, Jefferiss C, Bhalla AK, Beresford JN. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage. Rheumatology (Oxford). 2002;41:735-40.
17. Patel S, Patel G, Johnson D, Ogunremi L, Barron J. Effect of low dose weekly methotrexate on bone mineral density and bone turnover. Ann Rheum Dis. 2003;62:186-7.
18. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol. 1997;24:1489-94.
19. Minaur NJ, Kounali D, Vedi S, Compston JE, Beresford JN, Bhalla AK. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology (Oxford). 2002;41:741-9.
20. Carbone LD, Kaeley G, McKown KM, Cremer M, Palmieri G, Kaplan S. Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int. 1999;64:100-1.
21. Quinn MA, Green MJ, Gough AKS. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis. Ann Rheum Dis. 2003;62:1123-4.
22. Rozin AP. Is methotrexate osteopathy a form of bone idiosyncrasy? Ann Rheum Dis. 2003;62:1123.